Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predo...

por Spiller, Robin, Pélerin, Fanny, Cayzeele Decherf, Amélie, Maudet, Corinne, Housez, Béatrice, Cazaubiel, Murielle, Jüsten, Peter
Publicado 2015

Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis

por Cayzeele-Decherf, Amélie, Pélerin, Fanny, Leuillet, Sébastien, Douillard, Benoit, Housez, Béatrice, Cazaubiel, Murielle, Jacobson, Gunnard K, Jüsten, Peter, Desreumaux, Pierre
Publicado 2017

Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis

por Roselletti, Elena, Sabbatini, Samuele, Ballet, Nathalie, Perito, Stefano, Pericolini, Eva, Blasi, Elisabetta, Mosci, Paolo, Cayzeele Decherf, Amélie, Monari, Claudia, Vecchiarelli, Anna
Publicado 2019

Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis

por Pericolini, Eva, Gabrielli, Elena, Ballet, Nathalie, Sabbatini, Samuele, Roselletti, Elena, Cayzeele Decherf, Amélie, Pélerin, Fanny, Luciano, Eugenio, Perito, Stefano, Jüsten, Peter, Vecchiarelli, Anna
Publicado 2016